Casper Van Eijck

Erasmus University Rotterdam

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Collaborators (7)

Willem de Koning

Erasmus University Rotterdam

Joachim G. Aerts

Bharath Sampadi

Leiden University Medical Center

Marijke Melles

Delft University of Technology

Dirk Snelders

Delft University of Technology

Dana Mustafa

Assistant Professor, Leader of the Spatial Biology Facility

Paul Fockens

Professor and Chair

Amsterdam UMC

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Casper Van Eijck

Research Interests

Explore related searches

Contact this professor

Articles (15)

Collaborators (7)

Willem de Koning

Joachim G. Aerts

Bharath Sampadi

Marijke Melles

Dirk Snelders

Dana Mustafa

Paul Fockens

Make your next move.

Casper Van Eijck

Research Interests

Explore related searches

Contact this professor

Articles (15)

Immunogenicity and safety of COVID-19 vaccines in patients with pancreatic cancer

Ideal outcome after pancreatic resection for neuroendocrine tumors: a nationwide study

Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell–Mediated T-Cell Responses

Metformin boosts antitumor immunity and improves prognosis in upfront resected pancreatic cancer: an observational study

Improved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium Study

Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries—Profiling Blood Samples of Pancreatic Ductal Adenocarcinoma Patients

Long-term yield of pancreatic cancer surveillance in high-risk individuals

Immunomodulatory Effects of Stereotactic Body Radiotherapy and Vaccination with Heat-Killed Mycobacterium Obuense (IMM-101) in Patients with Locally Advanced Pancreatic Cancer

Treatment Response and Conditional Survival in Advanced Pancreatic Cancer Patients Treated with FOLFIRINOX: A Multicenter Cohort Study

Rintatolimod (Ampligen<sup>&reg;</sup>) Enhances Numbers of Peripheral B Cells and Is Associated with Longer Survival in Patients with Locally Advanced and Metastasized Pancreatic Cancer Pre-Treated with FOLFIRINOX: A Single-Center Named Patient Program

The Class I HDAC Inhibitor Valproic Acid Strongly Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Immune System Activation

The bigger picture of shared decision making

Organoids Derived from Neoadjuvant FOLFIRINOX Patients Recapitulate Therapy Resistance in Pancreatic Ductal Adenocarcinoma

Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study

Differential Expression of <i>BOC</i>, <i>SPOCK2</i>, and <i>GJD3</i> Is Associated with Brain Metastasis of ER-Negative Breast Cancers

Collaborators (7)

Willem de Koning

Joachim G. Aerts

Bharath Sampadi

Marijke Melles

Dirk Snelders

Dana Mustafa

Paul Fockens

Make your next move.

Rintatolimod (Ampligen<sup>®</sup>) Enhances Numbers of Peripheral B Cells and Is Associated with Longer Survival in Patients with Locally Advanced and Metastasized Pancreatic Cancer Pre-Treated with FOLFIRINOX: A Single-Center Named Patient Program